Background: Percutaneous ultrasound (US)-guided fine-needle aspiration (FNA) of adrenal gland lesions is controversial in veterinary medicine.
However, performing percutaneous US-guided FNA of adrenal lesions is controversial and remains an important debate in veterinary medicine. [4] [5] [6] [7] The risk of hypertensive crisis discourages veterinarians from the procedure, [4] [5] [6] [7] although evidence is only based on reports in the human literature. [8] [9] [10] [11] In veterinary medicine, risk assessment is anecdotal.
Bleeding, hematic contamination of the sample, and fear of spreading the neoplasm along the needle path are other concerns that may limit the general use of US-guided FNA of adrenal lesions. [12] [13] [14] [15] [16] A recent paper evaluated the clinical safety of this procedure. 17 One complication (ventricular tachycardia) was reported out of 23 percutaneous US-guided FNA of adrenal lesions. 17 The authors concluded that the procedure was relatively safe, including the 10 pheochromocytomas sampled. 17 In dogs, incidental masses of adrenal glands (AGs) are frequently detected on abdominal US and computed tomography (CT), with a prevalence of 4% and 9%, respectively. 18, 19 These can be primary tumors such as cortical adenoma, cortical carcinoma, pheochromocytoma, or metastases. 7, 20, 21 Potential differential diagnoses also include macronodular hyperplasia, cysts, granuloma, hematoma, and myelolipomas. 20, 21 Following adrenal lesion detection, it is crucial to determine its potential functionality (secreting versus nonsecreting), its origin (epithelial or neuroendocrine), its biological nature (malignant or benign), and its connection with adjacent vessels/organs. [4] [5] [6] [22] [23] [24] History, clinical signs, clinicopathological findings, endocrine tests and US, 25, 26 contrast-enhanced US, [27] [28] [29] [30] [31] and CT 32, 33 can assist in predicting the functional aspect of an adrenal lesion and in differentiating between a benign and malignant process. The aforementioned imaging modalities can provide an estimate of potential malignancy and can be extremely helpful in selecting the best therapeutic approach, but they cannot predict the histological type of the adrenal lesion. Several situations might complicate the diagnostic approach.
Secretory masses, in particular pheochromocytoma, can produce an insufficient amount of hormone and therefore less characteristic clinical signs and equivocal endocrine testing. 4, 5, [22] [23] [24] This confuses their identity with that of a nonsecretory tumor. Nonsecreting adrenal masses, in turn, are silent from a biochemical point of view and may complicate the diagnostic workup. 21 Different types of primary tumors may coexist, or each AG may be the site of a primary tumor. [34] [35] [36] [37] As the preoperative treatment 38, 39 and surgical approach differs from one adrenal tumor to another, [40] [41] [42] [43] [44] [45] prior knowledge of the tumor type before surgery is relevant and desirable.
The main objectives of this study were (1) to evaluate the frequency of percutaneous US-guided FNA of adrenal lesions performed by veterinary radiologists, radiologists' opinion about the procedure, and (2) to determine the incidence of adverse effects associated with it.
| MATERIALS AND METHODS
A multicenter retrospective study involving board-certified veterinary radiologists was conducted. Two consecutive online surveys, using a web-based application (Google forms, Google LLC, Mountain View, California) were distributed via e-mail. To collect the data, a dedicated e-mail account was created. Access to the data was password protected. Only 1 author had knowledge of the password. Anonymized results were then exported in a spreadsheet opened with a dedicated program (Microsoft Excel, Microsoft Corporation, Way Redmond, Washington), where no information allowing identification of the institutions, radiologists, clients, and dogs was present.
| First online survey
Approval of the American College of Veterinary Radiology (ACVR) and
European College of Veterinary Diagnostic Imaging (ECVDI) board secretaries was sought. An e-mail containing the link to the survey was sent directly by ACVR and ECVDI board secretaries, for privacy purposes. The first survey was a Knowledge, Attitude and Practice study. Before the start of the survey, a description of the aim and purposes of the study were provided. We emphasized that the survey would serve as a tool to further clinical knowledge. Radiologists were free to answer to the survey.
The first survey was initially submitted to answer the first objective of the study. It aimed at evaluating the percentage of veterinary radiologists performing the procedure, how frequently they performed it, and how often complications had been noted. We also asked the reasons why some radiologists were not performing FNAs on AG lesion.
For any reason other than those cited, a short answer box was provided. The first survey was sent accompanied by a brief description of the project. Questions of the survey are documented in Appendix S1.
| Second online survey
The second survey was sent to veterinary radiologists who had performed the procedure at least once in their career. This survey was intended to recruit cases and obtain data from the radiologists. This second survey contained specific questions regarding the clinical cases, referring particularly to the technique that was used and the potential complications, in order to evaluate the incidence of adverse events related to the procedure. Questions of the survey are documented in Appendix S2. 
| Case selection criteria

| Ultrasound reports review
From each US report and available US images, the following criteria were collected in an excel spreadsheet and reviewed: side and size (mm) of adrenal lesions, the dimension (mm) of the contralateral AG, echogenicity (hypoechoic, hyperechoic, or isoechoic to adjacent adipose tissue), echotexture (homogeneous, heterogeneous) and contours of the lesion (smooth or irregular), presence or absence of mineralization, and finally presence or absence of vascular invasion. 25, 26 The contralateral AG was considered atrophied when its maximal thickness was less than 5.0 mm. [46] [47] [48] Computed tomographic reports, when available, were also reviewed, in order to complete the diagnostic workup. The revision of the US and CT images was at the discretion of the radiologist who submitted the case, if the report was not complete enough to answer to aforementioned criteria.
| Fine-needle aspiration procedure review
The size of the needle (diameter in gauge and length in mm), the type of procedure (with aspiration or capillary), if other organs were aspirated, the presence of complications post-FNA within 48 hours, the cytological diagnosis, and, when available, the histopathological diagnosis (post-adrenalectomy or necropsy) were collected in an excel spreadsheet and reviewed.
| Statistical analysis
Descriptive methods were used to summarize findings. The data are reported as percentages and median values (range: minimum, maximum).
| RESULTS
| First online survey
The first online survey was sent to 977 board-certified radiologists. Of these, 138 responded to the survey, which represents a 14% participation rate. The results of the first online survey are depicted in Figure S1 . The results of the short answer box are reported in Table 1 . To the fourth T A B L E 1 List of other reasons (different from those cited and depicted in Figure 1 ) why veterinary radiologists would not perform percutaneous ultrasound-guided fine needle aspiration of the adrenal lesions observed adverse reactions associated with the procedure ( Figure S1D ).
Of these 15, 3 radiologists did not specify the type of complication and 12 gave details about the observed complications, which are tabulated in Table 2 . Regarding procedure-related hemorrhage, 1 radiologist specified that it was subjectively severe (but did not state if it required surgery) and 1 specified that it was mild. Regarding the 1 case of death, 1 died suddenly after the procedure and the other a few hours later. With the former case, a comment was added that it was a confirmed pheochromocytoma and that the dog was already in a critical condition before the procedure. One radiologist answered that they had never observed complications but had heard about adverse effects from colleagues. One reported a case of hypertension after the FNA of a hepatic metastasis resulting from a pheochromocytoma. Of 138 respondents, 53 (38%) were currently working in academia, 80 (58%) in private practice or teleradiology, and 5 (4%) in both academia and private practice.
| Second online survey
The second survey was sent to 65 radiologists, from the first survey who had performed the procedure at least once in their career (and not only to the 40 who declared currently performing it). Twelve of 65 (18%) positive answers were obtained, that is, radiologists willing to provide clinical cases to constitute a retrospective multicenter study. From these 12 radiologists, 50 dogs were collected, coming from 15 different centers (depending on where the radiologist was working at that time). Regarding the origin of the cases, 24 of 50 dogs were seen in the university teaching hospital or academic equivalent and 26 of 50 dogs were seen in private practice. Cases that fulfilled the inclusion criteria were obtained from 2003 to 2018.
| Signalment
Cross breed (19/50) and purebred dogs (31/50) were represented. Of the 50 dogs, 11 were intact males, 11 castrated males, 4 intact females, and 24 spayed females. The median age was 11 years (4-14 years) and the median body weight was 18 kg (6-57 kg). 
| Clinical diagnosis
| Diagnostic imaging
| DISCUSSION
This multicenter retrospective study confirmed that many veterinary clinicians believe percutaneous US-guided FNA of adrenal lesions to be unsafe. [4] [5] [6] [7] This contributes to the fact that it is not commonly performed.
From the first survey, it emerged that two thirds of radiologists currently do not perform FNAs of adrenal masses because of concern of potential adverse reactions. Although studies on the subject are limited 17 with a paucity of significant data, the procedure is still not recommended or to be performed with caution. [4] [5] [6] [7] Through the first survey it emerged that among radiologists who have performed the procedure in the past or currently still perform it, 78% have never encountered any complication while 22% report adverse effects. The most frequently reported complication was bleeding (7/12), followed by immediate or delayed (sev- there is only 1 recent reported case of adverse reaction following the FNA procedure. 17 The dog experienced ventricular tachycardia, but the authors of that study specified that the dog presented with this condition before the procedure, most likely due to the presence of pericardial effusion. Consequently, the association between this adverse reaction and the FNA procedure is questionable, and the possibility that the complication had been triggered by underlying heart disease was suggested.
In our study, in the dogs that developed mild hemorrhage following the FNA procedure, results of a coagulation profile were not available; therefore, it was not possible to exclude a possible correlation between bleeding and an underlying coagulopathy. 15 In these dogs, the procedure was equally performed under sedation/general anesthesia and with different FNA techniques (different needle size and different aspiration/capillary technique). In the veterinary literature, a study was carried out on the association between abnormalities in the coagulation profile and the risk of bleeding following an US-guided biopsy of abdominal organs. 15 This study showed that in dogs, a prolonged prothrombin time increased the probability of hemorrhage following the procedure and that thrombocytopenia predisposed to severe hemorrhages, requiring transfusion or fluid therapy.
The dog in our study that died of respiratory distress 28 hours following the procedure had Wobbler syndrome (caudal cervical spondylomyelopathy) and laryngeal paralysis in addition to the adrenal mass. The laryngeal paralysis may have contributed to the acute respiratory distress and is most likely the cause of death. However, this assumption could not be verified. Cytological analysis suspected a pheochromocytoma in this dog, raising the possibility that tachycardia and acute respiratory distress were triggered by the release of catecholamines following the aspiration of the mass. However, these complications occurred 28 hours after the procedure, while the half-life of the catecholamines is extremely short. 49 Since pheochromocytoma is a neoplasm that is often characterized by intermittent release of catecholamines, the distress displayed by the dog may have been due to the release of adrenaline and noradrenaline by the adrenal mass, independent of the FNA procedure.
In addition to the aforementioned recently published study, 17 no other studies are available in the veterinary literature regarding complications adrenal aspiration. A similar retrospective study was recently conducted to investigate the incidence of complications of percutaneous US-guided FNA of the pancreas in dogs. 50 In this study, the percentage of complications following the procedure was also low (6.3%), similar to our results and those of Sumner et al (2018),
suggesting that these techniques are not as dangerous as it is commonly believed. Studies have been carried out in the past on USguided FNA of other abdominal organs, such as liver and spleen. They concluded that this procedure is minimally invasive and almost free of complications. [51] [52] [53] Studies in human literature report that the percentage of complications subsequent to FNA of the liver is around 0.5% and that mortality is extremely rare (0.01%). 54, 55 In our study, bleeding occurred in 1 dog in which a spinal needle (22-G; 63 mm) was used instead of a hypodermic needle and this could have influenced the risk of bleeding. In general, hypodermic, 22-to 25-gauge needles are commonly used for FNA of abdominal organs. 1, 2 In veterinary literature, the few cases of adrenal aspiration described in the dog do not report the type of needle used. In the most recent study, 17 it is specified that because of the retrospective nature of the study, these technical details about the procedure were not available but that a 25-gauge/38-mm hypodermic needle is routinely used in the clinic from which the cases were collected. No bleeding or other complications were reported following FNA. 17 In the first survey, a radiologist reported the presence of adhesions at the FNA puncture site between the adrenal lesion and adjacent organs/tissue (cf. Table 2 ). This was observed during the adrenalectomy by the surgeon and complicated the surgery. Metastatic spread along the needle tract has not been reported in dogs with adrenal tumors but has been described in humans, 16 and with FNA of carcinomas of other origin (eg, transitional cell carcinoma). 58 In our case, it was not specified whether the adjacent tissue to which the adrenal lesion was adherent, was infiltrated by tumor or not.
Our Although the complication rate associated with the procedure seems low, is it worth taking the risk for the sake of a thorough clinical workup? There are probably a few clinical situations where percutaneous US-guided FNA of adrenal lesions is indicated, and there is no current consensus regarding the diagnostic workup of incidentaloma in dogs, despite the high incidence reported on US and CT. 20, 21, 59 The authors thought that the scientific community had to be informed of the low magnitude of the risk associated with this procedure when it is clinically indicated.
Even though 5 of 8 dogs were suspected to have pheochromocytoma according to cytological analysis, only 1 dog was pretreated with phenoxybenzamine before surgery. This goes a little against 1 of the main advantages of a presurgical FNA, as phenoxybenzamine-treated dogs had a significantly decreased death rate compared with untreated dogs. 39 The main limitations of our study rely on the low participation rate (14%). Although still in the range (10%-15%) of the expected participation rate for an external survey (versus 30%-40% for internal survey), 60 one can argue that the nonresponse bias may have an important impact on the value of these results. Although the impact of nonresponse bias on results cannot be as easily quantified as sampling error can, response rate can be used as one way to gauge the potential for nonresponse bias. The higher the response rate of a survey, the lower the risk of nonresponse bias. Even though the participation rate remains in the "acceptable" range, the high nonresponse bias may undermine the reliability of the results of the study, and this is not something that we could quantify. The other main limitation of the study is the potential selection bias in the recruitment of the cases. Radiologists who had decided to participate in the study may already have a strong opinion on the safety of percutaneous USguided FNA of adrenal lesions and decided to participate in order to confirm their belief. 61, 62 In the same manner, participation to the first survey may have been influenced by the personal conviction on the topic and introduced a selection bias. Although we attempted not to use leading questions type in the first survey, we cannot assess if these questions could sway the respondents toward a particular answer. No assumption was indicated in the title of the questions to avoid encouraging a certain answer from the respondent. 61, 62 However, we provided specific options to select and despite the option for 
